These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 722219)

  • 1. Utility of pharmacokinetics in designing toxicological protocols and improving interspecies extrapolation.
    Young JF; Holson JF
    J Environ Pathol Toxicol; 1978; 2(1):169-86. PubMed ID: 722219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonlinear pharmacokinetics relative to toxicity and use of toxicological data.
    Ramsey JC
    Drug Metab Rev; 1982; 13(5):779-97. PubMed ID: 6754308
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of pharmacokinetic principles in the extrapolation of animal data to humans.
    Gillette JR
    Clin Toxicol; 1976; 9(5):709-22. PubMed ID: 1000904
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of pharmacokinetics as an interpretive and predictive tool in chemical toxicology testing and risk assessment: a position paper on the appropriate use of pharmacokinetics in chemical toxicology.
    Frantz SW; Beatty PW; English JC; Hundley SG; Wilson AG
    Regul Toxicol Pharmacol; 1994 Jun; 19(3):317-37. PubMed ID: 8090955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors to consider when selecting animal models for postnatal teratology studies.
    Stanton HC
    J Environ Pathol Toxicol; 1978; 2(1):201-10. PubMed ID: 722221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of inhaled gases and vapors.
    Andersen ME
    Neurobehav Toxicol Teratol; 1981; 3(4):383-9. PubMed ID: 6278342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What happens in the skin? Integrating skin permeation kinetics into studies of developmental and reproductive toxicity following topical exposure.
    Dancik Y; Bigliardi PL; Bigliardi-Qi M
    Reprod Toxicol; 2015 Dec; 58():252-81. PubMed ID: 26475253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
    Gabrielsson J; Green AR
    J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
    Kirman CR; Sweeney LM; Corley R; Gargas ML
    Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and kinetic aspects of toxicological studies. 19 May 1987, Paris, France.
    Xenobiotica; 1988 Jan; 18 Suppl 1():1-96. PubMed ID: 3344587
    [No Abstract]   [Full Text] [Related]  

  • 12. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents).
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of interspecies difference in hepatobiliary transporters to improve extrapolation of human biliary secretion.
    Lai Y
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1175-87. PubMed ID: 19611403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mink as a predictive model in toxicology.
    Calabrese EJ; Aulerich RJ; Padgett GA
    Drug Metab Rev; 1992; 24(4):559-78. PubMed ID: 1289038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using ontogeny information to build predictive models for drug elimination.
    Alcorn J; McNamara PJ
    Drug Discov Today; 2008 Jun; 13(11-12):507-12. PubMed ID: 18549977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal extrapolation in environmental health: its theoretical basis and practical applications.
    Reichsman FP; Calabrese EJ
    Rev Environ Health; 1979; 3(1):59-78. PubMed ID: 538297
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics in chronic animal toxicity studies.
    Yacobi A; Kamath BL; Lai CM
    Drug Metab Rev; 1982; 13(6):1021-51. PubMed ID: 6754316
    [No Abstract]   [Full Text] [Related]  

  • 18. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of ADMET Properties.
    Norinder U; Bergström CA
    ChemMedChem; 2006 Sep; 1(9):920-37. PubMed ID: 16952133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An introduction to metabolic and kinetic aspects of toxicological studies.
    Davies DS
    Xenobiotica; 1988 Jan; 18 Suppl 1():3-7. PubMed ID: 3344589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.